← Feed
📰 **Arvinas Secures First FDA Approval With VEPPANU For ESR-1 Mutated Advanced Breast Cancer **
(RTTNews) - Arvinas, Inc. (ARVN), together with Pfizer Inc. (PFE), announced that the U.S. FDA has approved VEPPANU for adult patients with estrogen receptor-positive (ER+)/HER2-negative, ESR1-mutated advanced or metastatic breast cancer, following disease progression after at le...
🔗 https://www.nasdaq.com/articles/arvinas-secures-first-fda-approval-veppanu-esr-1-mutated-advanced-breast-cancer
#markets #news
(RTTNews) - Arvinas, Inc. (ARVN), together with Pfizer Inc. (PFE), announced that the U.S. FDA has approved VEPPANU for adult patients with estrogen receptor-positive (ER+)/HER2-negative, ESR1-mutated advanced or metastatic breast cancer, following disease progression after at le...
🔗 https://www.nasdaq.com/articles/arvinas-secures-first-fda-approval-veppanu-esr-1-mutated-advanced-breast-cancer
#markets #news